CABALETTA BIO, INC. in the interest of investors
Cabaletta Bio (NASDAQ:CABA) was founded in 2017. The company is headquartered in Philadelphia, PA, USA. The company is focused on developing T-cell therapeutics for the treatment of autoimmune diseases. The company collaborates with a number of professional institutions such as the University of Pennsylvania, Children’s Hospital of Philadelphia, and biotechnology company IASO Bio. The company […]